How does Glimepiride differ from SGLT2 inhibitors in its glucose-lowering action? Are there complementary benefits when these drugs are combined?
Lakshya KumarExplorer
How does Glimepiride differ from SGLT2 inhibitors in its action on blood glucose?
Share
Glimepiride stimulates insulin release from pancreatic β-cells, whereas SGLT2 inhibitors block glucose reabsorption in kidneys, lowering blood glucose. Combined, they offer dual action, potentially improving glycemic control.